Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb 20;21(4):1430.
doi: 10.3390/ijms21041430.

Endocrine-Disrupting Chemicals in Human Fetal Growth

Maria Elisabeth Street  1 , Sergio Bernasconi  2
Affiliations
Review

Endocrine-Disrupting Chemicals in Human Fetal Growth

Maria Elisabeth Street et al. Int J Mol Sci. .

Abstract

Fetal growth is regulated by a complex interaction of maternal, placental, and fetal factors. The effects and outcomes that chemicals, widely distributed in the environment, may have on the health status of both the mother and the fetus are not yet well defined. Mainly mixtures of chemical substances are found in the mothers and placenta. Exposure to endocrine-disrupting chemicals (EDCs) can be associated with fetal growth retardation, thyroid dysfunction, and neurological disorders. EDCs mostly interfere with insulin, glucocorticoid, estrogenic, and thyroid pathways, with subsequent effects on normal endocrine and metabolic functions, which cause changes in the epigenome and state of inflammation with life-long effects and consequences. International scientific societies recommend the implementation of research and of all possible preventive measures. This review briefly summarizes all these aspects.

Keywords: birth weight; developmental origins of health and disease (DOHAD); endocrine-disrupting chemicals (EDCs); fetal growth restriction (FGR); intrauterine growth restriction (IUGR); placenta; postnatal outcomes; pregnancy; preterm birth; small for gestational age (SGA).

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Sferruzzi-Perri A.N., Vaughan O.R., Forhead A.J., Fowden A.L. Hormonal and nutritional drivers of intrauterine growth. Curr. Opin. Clin. Nutr. Metab. Care. 2013;16:298–309. doi: 10.1097/MCO.0b013e32835e3643. - DOI - PubMed
    1. Finken M.J.J., Van der Steen M., Smeets C.C.J., Walenkamp M.J.E., de Bruin C., Hokken-Koelega A.C.S., Wit J.M. Children Born Small for Gestational Age: Differential Diagnosis, Molecular GeneticEvaluation, and Implications. Endocr. Rev. 2018;39:851–894. doi: 10.1210/er.2018-00083. - DOI - PubMed
    1. Street M.E., Seghini P., Ziveri M.A., Fieni S., Volta C., Neri T.M., Viani I., Bacchi-Modena A., Bernasconi S. Interleukin-6 and insulin-like growth factor system relationships and differences in the human placenta and fetus from the 35th week of gestation. Growth Horm. IGF Res. 2006;16:365–372. doi: 10.1016/j.ghir.2006.09.007. - DOI - PubMed
    1. Bloise E., Ciarmela P., Dela Cruz C., Luisi S., Petragia F., Reis F.M. Activin A in mammalian Physiology. Physiol. Rev. 2019;99:739–780. doi: 10.1152/physrev.00002.2018. - DOI - PubMed
    1. Mørck T.J., Sorda G., Bechi N., Rasmussen B.S., Nielsen F., Ietta F., Rytting E., Mathiesen L., Paulesu L., Knudsen L.E. Placental transport and in vitro effects of Bisphenol A. Reprod. Toxicol. 2010;30:131–137. doi: 10.1016/j.reprotox.2010.02.007. - DOI - PubMed

MeSH terms

Substances